describes an inclusive biophysical, microscopic and computational study establishing that L-3, 4-dihydroxyphenylalanine (Levodopa) to be promising against the inhibition and disaggregation of thermally induced amyloid…
system based on chitosan (CS) and poly vinyl alcohol (PVA) for nasal delivery of Levodopa. The hydrogel was prepared by mixing the chitosan and poly vinyl alcohol. The concentration ... 37ºC within 12-15 minutes with…
Statement of the Problem: Levodopa is a standard treatment for Parkinson disease (PD). However, its long-term therapy is associated with motor fluctuations and levodopa induced dyskinesia ... these motor complications…
Levodopa has been widely used to treat symptoms of Parkinson’s Disease (PD); it is regarded as the most effective therapy for PD at present. Although the usage of levodopa ... China, there is no systematic review to…
Background: Long-term levodopa therapy relieves the motor dysfunction associated with Parkinson's disease (PD), but it has variable effects on non-motor symptoms including cognitive dysfunction, hallucinations, and…
Background: The GIT infection with Helicobacter pylori (HP) can inhibit levodopa (LD) in Parkinson's disease (PD) patients leading to motor fluctuation. Objectives: To identify the incidence
recent emerge of new therapies in the symptomatic treatment of Parkinson's disease (PD), Levodopa remains the gold standard treatment for almost 50 years. It is the most effective drug ... particular. As the…
Background: Levodopa is used in the treatment of Parkinson. It get absorbed from small intestine, but Levodopa get metabolized in peripheral tissues by L-aromatic amino acid decarboxylase (AAAD) enzyme ... which…
Objective: To observe neuronal toxical effect of Levodopa and investigate whether using Levodopa together with EGb is an ideal, workable method to treat Parkinson disease. Methods: In this study ... rotational…
Objective: To evaluate the neuronal toxicical effects induced by levodopa and explore the method in which PD can be treated reasonably with levodopa. Method: The rat models of Parkinson disease ... different durations…
blood-brain barrier (BBB) function and volumetry associated with Parkinson’s disease (PD) levodopa-induced-dyskinesia (LID). Methods: 26 PD patients [13 with LID (LID+) and 13 without (LID-)], matched
possible formation of a host-guest complex between levodopa and HP-β-CD was studied accordingly. A simple phase-solubility study was conducted based on the method proposed by Higuchi ... Connors. The complexation…
after its necessary and prolonged use most patients often develop side effects, known as levodopa-induced dyskinesia (LID). The management of LID usually requires therapeutic intervention, and the only available…
ganglia. Conventional therapy includes surgery that involves a lot of risk and administration of levodopa which is accompanied by poor bioavailability, short half-life, and side effects. In this present ... injected…
clinical practice that may be iatrogenically induced. Hereby we report a case of Levodopa induced hypokalemia in a 73 year old female patient with Parkinson’s disease. She symptomatically improved
analysis of generic drug products. The paper deals with the pharmaceutical formulation - Entacapone, Levodopa and Carbidopa tablets for the treatment of Parkinson’s disease. The paper presents a simple ... been…
Levodopa forms stable complexes with Fe(II) and Fe(III). To study the interaction of LD with different oxidation states of iron in non-buffered as well as in buffered ... Stoichiometry is 1:3 and the log Kf value stands…
accurate reverse phase liquid chromatographic method was developed for the simultaneous estimation of Levodopa (LD) and Carbidopa (CD) in bulk and pharmaceutical dosage forms. A Phenomenex C18- RP Aqueous reverse
This investigation is aimed formulate controlled release matrix tablets containing 100mg of Levodopa (LD), 25mg of Carbidopa (CD) using different hydrophilic matrix forming polymers like HPMC (K4M, K15M, LVCR
Levodopa- Carbidopa combination of orally disintegration tablet used in the treatment of parkinsonism was formulated and prepared by direct compression method and evaluated results were compared with marketed tablets
matrix tablet by employing various mathematical models. A study was done with Carbidopa and Levodopa ER tablets, 50 mg/200 mg by employing wet granulation technique using Hydroxypropyl methylcellulose ... high degree of…
environmentally friendly direct injection high-performance liquid chromatography (HPLC) method for the determination of levodopa (LD) and carbidopa (CD) in human serum has been developed and validated. The method
person unable to control movement normally. The test drug Ginkgolide B and standard drug Levodopa have targeted the protein D2 receptor (PDB ID: 2YOU) and protein D3 receptor